BioScience Laboratories Collaborates With Synomics

BioScience Laboratories and Synomics Pharmaceutical have reported their formal partnership to provide a fully integrated phase 1 clinical study capability for trials in healthy human subjects. The objective of both the firms is to provide drug manufacturers with a single source for outsourcing clinical trials.

Reportedly, the partnership between BioScience Laboratories and Synomics allows a single point of project management with the full array of bioanalytical and clinical trials capabilities.

John Pirro, vice president and chief operating officer of Synomics, said: “Synomics’ comprehensive quality management system reduces regulatory risk. The alliance between Synomics and BioScience Laboratories produces a versatile topical clinical phase I trial service offering that will be highly beneficial to the industry.”

BioScience Laboratories seeks to provide antimicrobial product testing and result interpretation grounded in science. The company assist its clients through product testing and aid in the development of new products and new markets. It offers a variety of laboratory services and guidance regarding federal regulatory agency requirements for the healthcare, pharmaceutical, personal care and consumer products markets.

Synomics Pharmaceutical Services is a global Contract Research Organization (CRO), specializing in customized, pre-clinical and clinical bioanalytical services, storage stability services, and analytical chemistry services for the pharmaceutical, personal care, and allied industries.